by Lengea Law | Oct 10, 2024 | News
The pharmaceutical landscape is once again at the center of a legal battle. This time, the battle involves the popular drug tirzepatide, manufactured by Eli Lilly under the brand name Mounjaro. Compounders, the small but crucial segment of the pharmaceutical world,...
by Lengea Law | Oct 3, 2024 | News
Recent developments regarding weight loss drugs and the FDA’s policies on compounding pharmacies have sparked significant changes in the healthcare and wellness sectors. With the FDA announcing that Eli Lilly’s popular weight loss drug, Tirzepatide, is no longer...
by Lengea Law | Aug 21, 2024 | News
August 21, 2024 In a landmark decision, Judge Ada Brown of the United States District Court for the Northern District of Texas has overruled the Federal Trade Commission’s (FTC) sweeping ban on non-compete agreements. This ruling marks a significant development...
by Lengea Law | Aug 14, 2024 | News
The beauty industry never stands still, constantly unveiling new and innovative treatments. Two recent additions that have generated buzz are the salmon sperm facial and exosome therapy. While these treatments promise remarkable results, it’s essential to...
by Lengea Law | Jul 29, 2024 | News
In a significant shift, the Supreme Court has restricted the regulatory authority of federal agencies, complicating their efforts to oversee environmental, public health, and workplace safety issues. The Court’s 6-3 decision dismantled the 1984 Chevron ruling,...
by Lengea Law | Jul 8, 2024 | News
On July 3, 2024, a Federal Court in Texas issued a preliminary injunction, blocking implementation of the Federal Trade Commission’s (“FTC”) rule (the “Rule”) banning non-compete agreements. It should be noted that the effect of the injunction is limited to the...
